SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.
0 references·11 citing·37 second hop
Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid testing for…Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Three-Year Experience in NAT …Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Nucleic acid amplification te…NAT positivity in seronegative voluntary blood donors from western India (2016)NAT positivity in seronegativ…Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India (2016)Comparison of Procleix Ultrio…Prevalence and Trends of Common Transfusion Transmitted Infections Using Serological and Nucleic Acid Markers in Saudi Blood Donors (2015)Prevalence and Trends of Comm…Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Individual donor-nucleic acid…Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)Screening Donated Blood for T…Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity (2014)Nucleic A cid T echnology ( N…Legal and ethical issues in safe blood transfusion (2014)Legal and ethical issues in s…Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan (2014)Estimating window period bloo…A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India (2014)A Cross-Sectional Study on Bu…Transfusion-transmitted infections (2007)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)Time Trend and Prevalence Analysis of Transfusion Transmitted Infections among Blood Donors: A Retrospective Study from 2001 to 2016 (2023)Study of Blood-transfusion Services in Maharashtra and Gujarat States, India (2009)Moving on from voluntary non‐remunerated donors: who is the best blood donor? (2011)Hemovigilance Program-India (2013)Current status of blood banks in India (2016)Revolutionizing blood bank inventory management using the TOC thinking process: An Indian case study (2017)A review of legal, regulatory, and policy aspects of blood transfusion services in India (2021)Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Kuppuswamy's socioeconomic status scale-updating for 2007. (2007)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)What is the evidence for the change in the blood donation deferral period for high-risk groups and does it go far enough? (2018)Risks and challenges of HIV infection transmitted via blood transfusion (2019)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. (2015)Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification test (2019)Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Transfusion Transmissible Infections: Maximizing Donor Surveillance (2018)The Prevalence of Transfusion Transmitted Infections among Blood Donors in Pakistan: A Retrospective Study (2021)The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review (2022)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers (2025)Trend of transfusion transmitted infections frequency in blood donors: provide a road map for its prevention and control (2012)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2014Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience44 cited
  • 2017Nucleic acid amplification testing in Indian blood banks: A review with perspectives39 cited
  • 2015Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety35 cited
  • 2017Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia30 cited
  • 2014Legal and ethical issues in safe blood transfusion22 cited
  • 2014Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan19 cited
  • 2014A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India17 cited
  • 2014Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity16 cited
  • 2016Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India15 cited
  • 2015Prevalence and Trends of Common Transfusion Transmitted Infections Using Serological and Nucleic Acid Markers in Saudi Blood Donors15 cited
  • 2016NAT positivity in seronegative voluntary blood donors from western India

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

11 cited